Improving Maternal and Child Health Through Point-of-care STI Testing
Emory University · with National Institute on Minority Health and Health Disparities (NIMHD) · NCT07290439
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 756
- US sites recruiting
- 1
- Study start
- August 11, 2026
- Record last updated
- August 19, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to learn if point-of-care tests (POCTs) for sexually transmitted infections (STIs) improve the timely treatment of syphilis, chlamydia, gonorrhea, and trichomonas in pregnant women. It will also learn about the feasibility, acceptability, and cost-effectiveness of implementing POCTs in a large safety-net hospital setting.
The main questions it aims to answer are
- Do POCTs reduce delays in STI treatment compared with standard laboratory-based testing?
- What barriers, facilitators, and processes affect POCT implementation in prenatal and obstetric care?
- What are the costs and cost-effectiveness of POCTs compared with standard testing?
Participants will
- Complete a baseline survey and receive either POCTs (fingerstick blood draw or vaginal swab) or standard laboratory STI testing.
- If diagnosed with an STI, complete a follow-up survey approximately one month later.
- Stakeholders (providers, hospital leadership, and public health officials) will complete interviews to inform implementation strategies.
Being studied: Point-of-care STI tests; Standard of care STI testing
Conditions: Treponema Pallidum Infection; Chlamydia Trachomatis Infection; Neisseria Gonorrheae Infection; Trichomonas Vaginalis Vaginitis; Sexually Transmitted Infection
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Pregnant and clinically indicated for STI testing (syphilis and/or Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV) at a prenatal care (PNC ) or labor and delivery (L\&D) triage visit at Grady Memorial Hospital (GMH). Indications for STI testing in pregnancy at GMH:
- Syphilis, CT, NG, and TV indicated at first PNC visit
- Syphilis serologic testing additionally indicated in 3rd trimester and at delivery
- CT/NG/TV additionally indicated in the 3rd trimester for those \<25 or with increased risk [1]
- Additional testing recommended based on clinical signs or symptoms (e.g., genital lesion or vaginal discharge, new exposure history)
- English or Spanish-speaking
- If \<16 years of age, has a parent or legal guardian present
- Have STI risk factor:
- \<25 years of age
- Reports current substance use
- Reported or documented history of a positive STI
- More than one current sex partner
- A current sex partner who has concurrent partners
- A new sex partner (\<6 months )
- A current sex partner who has an STI
- Exchange of sex for money or drugs
- Incarceration
- No previous prenatal care during the current pregnancy
- Able to follow study procedures and provide written informed consent or assent, as appropriate
Exclusion Criteria
- Indicated for syphilis test: negative RPR test during this pregnancy
- Indicated for syphilis test: ever had a previous syphilis diagnosis (lifetime history)
- Indicated for CT/NG/TV test: negative for all three of CT, NG, and TV within the previous 1 month
- Indicated for CT/NG/TV test: positive for any of CT, NG, and/or TV and completed treatment \<3 weeks prior
Stakeholders
- GMH PNC or L\&D providers, GMH leadership, Georgia Dept of Health leadership
- >=18 years of age
- Able to follow study procedures and provide verbal informed consent
Recruiting US locations
Grady Memorial Hospital
Atlanta, GA 30303
Site contact: Kimberly Workowski, MD · 404-686-7893 · kworkow@emory.edu
Study contacts (from the official record)
- Kristin Wall, PhD · (404)-616-0600 · kmwall@emory.edu
- Kimberly Workowski, MD · kworkow@emory.edu
Similar studies in Georgia
All pregnancy studies in Georgia →- RecruitingHealthy volunteers
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
Thrive Neuromedical, LLC
- Location
- Atlanta, GA
- Eligibility basics
- Ages 7 mo–8 mo
- RecruitingPhase 2
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Seaport Therapeutics
- Location
- Atlanta, GA + 26 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S
- Location
- Atlanta, GA + 21 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Lipocine Inc.
- Location
- Decatur, GA + 15 other US sites
- Eligibility basics
- Ages 15–45 · Women only